Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cizeau

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Infection Control and Hospital Epidemiology|September 23, 2000
Comparison of systematic versus selective screening for methicillin-resistant Staphylococcus aureus carriage in a high-risk dermatology wardE Girou, J Azar, P Wolkenstein, et al.
Drug Design, Development and Therapy|December 15, 2010
A Phase I study of an intravesically administered immunotoxin targeting EpCAM for the treatment of nonmuscle-invasive bladder cancer in BCGrefractory and BCG-intolerant patientsMark Kowalski, Joycelyn Entwistle, Jeannick Cizeau, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 4, 2016
Trastuzumab-deBouganin Conjugate Overcomes Multiple Mechanisms of T-DM1 Drug ResistanceRachelle L Dillon, Shilpa Chooniedass, Arjune Premsukh, et al.
Drug Design, Development and Therapy|November 19, 2009
A phase I clinical study of VB4-845: weekly intratumoral administration of an anti-EpCAM recombinant fusion protein in patients with squamous cell carcinoma of the head and neckGlen C MacDonald, Michèle Rasamoelisolo, Joycelyn Entwistle, et al.
The Journal of Hospital Infection|June 9, 2004
Misuse of gloves: the foundation for poor compliance with hand hygiene and potential for microbial transmission?E Girou, S H T Chai, F Oppein, et al.
The Journal of Hospital Infection|June 11, 2017
Contribution and limits of clinical specimens for the screening of intestinal multi-drug-resistant bacteria in view of laboratory automationA Geraud de Galassus, F Cizeau, A Agathine, et al.
Molecular and Cellular Biology|July 13, 2000
BNIP3 and genetic control of necrosis-like cell death through the mitochondrial permeability transition poreC Vande Velde, J Cizeau, D Dubik, et al.
Journal of Biomolecular Screening|December 7, 2010
Fusogenics: a recombinant immunotoxin-based screening platform to select internalizing tumor-specific antibody fragmentsJeannick Cizeau, Marianne G P Torres, Sharla G Cowling, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 8, 2025
Unexpected natural cefiderocol resistance in Stenotrophomonas maltophilia associated to the genogroup 4 genetic backgroundCéline Sakr, Maxime Danjean, Florence Cizeau, et al.
Molecules (Basel, Switzerland)|December 22, 2016
DeBouganin Diabody Fusion Protein Overcomes Drug Resistance to ADCs Comprised of Anti-Microtubule AgentsShilpa Chooniedass, Rachelle L Dillon, Arjune Premsukh, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Infection Control and Hospital Epidemiology|September 23, 2000
Comparison of systematic versus selective screening for methicillin-resistant Staphylococcus aureus carriage in a high-risk dermatology wardE Girou, J Azar, P Wolkenstein, et al.
Drug Design, Development and Therapy|December 15, 2010
A Phase I study of an intravesically administered immunotoxin targeting EpCAM for the treatment of nonmuscle-invasive bladder cancer in BCGrefractory and BCG-intolerant patientsMark Kowalski, Joycelyn Entwistle, Jeannick Cizeau, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 4, 2016
Trastuzumab-deBouganin Conjugate Overcomes Multiple Mechanisms of T-DM1 Drug ResistanceRachelle L Dillon, Shilpa Chooniedass, Arjune Premsukh, et al.
Drug Design, Development and Therapy|November 19, 2009
A phase I clinical study of VB4-845: weekly intratumoral administration of an anti-EpCAM recombinant fusion protein in patients with squamous cell carcinoma of the head and neckGlen C MacDonald, Michèle Rasamoelisolo, Joycelyn Entwistle, et al.
The Journal of Hospital Infection|June 9, 2004
Misuse of gloves: the foundation for poor compliance with hand hygiene and potential for microbial transmission?E Girou, S H T Chai, F Oppein, et al.
The Journal of Hospital Infection|June 11, 2017
Contribution and limits of clinical specimens for the screening of intestinal multi-drug-resistant bacteria in view of laboratory automationA Geraud de Galassus, F Cizeau, A Agathine, et al.
Molecular and Cellular Biology|July 13, 2000
BNIP3 and genetic control of necrosis-like cell death through the mitochondrial permeability transition poreC Vande Velde, J Cizeau, D Dubik, et al.
Journal of Biomolecular Screening|December 7, 2010
Fusogenics: a recombinant immunotoxin-based screening platform to select internalizing tumor-specific antibody fragmentsJeannick Cizeau, Marianne G P Torres, Sharla G Cowling, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 8, 2025
Unexpected natural cefiderocol resistance in Stenotrophomonas maltophilia associated to the genogroup 4 genetic backgroundCéline Sakr, Maxime Danjean, Florence Cizeau, et al.
Molecules (Basel, Switzerland)|December 22, 2016
DeBouganin Diabody Fusion Protein Overcomes Drug Resistance to ADCs Comprised of Anti-Microtubule AgentsShilpa Chooniedass, Rachelle L Dillon, Arjune Premsukh, et al.
Pageof 4